You’ve probably never heard of Trikafta — unless you or someone you love lives with cystic fibrosis. The drug has fundamentally changed cystic fibrosis care, extending life expectancy by decades. But the drug costs $326,000 a year — and requires people to be on it for life. Abdul reflects on the central challenge at promoting life-saving innovations that the people who need them can afford. Then he interviews Dr. Michael Boyle, President and CEO of the Cystic Fibrosis Foundation about the science behind Trikafta and the work to make it universally affordable.
This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by:
Marguerite Casey Foundation: Sign up for their new Summer School program at CaseyGrants.org/SummerSchool.
Rhone: Upgrade your closet with Rhone and use AD to save 20% at https://www.rhone.com/AD.
